Hepcinat 400 mg & NATDAC 60mg

Hepcinat 400 mg Sofosbuvir Tablets

Sofosbuvir is a nucleotide analog NS5B polymerase inhibitor used in combination with other antiviral drugs for the treatment of chronic hepatitis C virus (HCV) infection. It is used in combination with other antiviral drugs for the treatment of chronic hepatitis C virus (HCV) infection.

Sofosbuvir is a medication which is used for treating hepatitis in patients and is sold under the brand name of Sovaldi. This medication is used for treating hepatitis C and cannot be used for treating any other disease.

Hepcinat 400 mg Sofosbuvir Tablets-Generic Sovaldi Sofosbuvir is a medication used to treat Hep C. Available in India as under brand name Hepcinat Tablets. It is to used cure people of the Hep C virus along with combination of other medications (peginterferon alfa and ribavirin, or ribavirin alone). Hepcinat is taken at a dose of 400 mg once per day. It doesn’t need to be taken with food.

So far, sofosbuvir appears to have few side effects and these are associated with the other medications sofosbuvir is taken with. Hep C treatment can cure a person from Hep C. However, a person could be infected again.

NATDAC 60mg – Manufactured and Marketed by NATCO PHARMA LIMITED, INDIA. … Each film coated tablet contains: Daclatasvir Dihydrochloride equivalent to Daclatasvir 60 mg . Natdac (Daclatasvir Dihydrochloride) is a treatment for chronic hepatitis C virus (HCV) genotype 1 or genotype 3 infection. It is always prescribed with sofosbuvir.